Geneos Wealth Management Inc. Night Hawk Biosciences, Inc. Transaction History

Geneos Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.1 - $3.54 $3,150 - $5,310	-1,500 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$3.04 - $6.01 $3 - $6	-1 Reduced 0.07%	1,500 $4,000
Q3 2021 Nov 09, 2021	BUY	$5.9 - $7.44 $5 - $7	1 Added 0.07%	1,501 $9,000
Q1 2021 Jun 17, 2021	BUY	$5.67 - $12.54 $8,505 - $18,810	1,500 New	1,500 $10,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.